Watch Ticker

Anixa Biosciences, Inc.

Go to Anixa Biosciences, Inc. Website

$3.10

0.09 (2.99%)

Live

Previous Close

$2.98

Day Range

$2.9 - $3.09

Previous Day Range

$3 - $3.1

Market Cap

$99.9 million USD

Day Vol.

165560

Previous Day Vol.

58025

Currency

USD

Primary Exchange

Nasdaq

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024

Anixa Biosciences, a biotechnology company focused on cancer treatment and prevention, will present at the Sidoti Micro-Cap Virtual Conference on November 13-14, 2024. The company will provide updates on its breast cancer and ovarian cancer clinical trials, which have been producing positive results.

Related tickers: ANIX.

Read Full Article

Vandana Singh - EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy - Benzinga

The FDA has approved Anixa Biosciences' application for an individual patient trial of its CAR-T therapy for recurrent ovarian cancer patients who have failed standard-of-care treatments. The therapy has shown promising early results, with one patient demonstrating a notable response despite initial tumor progression.

Related tickers: ANIX.

Read Full Article

Trending Tickers

Please sign in to view